Humphrey matrix perimetry in optic nerve and chiasmal disorders: Comparison with humphrey SITA Standard 24-2

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 3, 2008, Pages 917-923

  Huang, Charles Q ^a   Carolan, James ^a   Redline, Daniel ^a   Taravati, Parisa ^b   Woodward, Kimberly R ^b   Johnson, Chris A ^c   Wall, Michael ^b   Keltner, John L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c DEVERS EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUTOMATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPTIC CHIASM; OPTIC NERVE; PERIMETRY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VISUAL FIELD; ALGORITHM; COMPUTER PROGRAM; METHODOLOGY; MIDDLE AGED; OPTIC NERVE DISEASE; PATHOLOGY; REPRODUCIBILITY; VISUAL DISORDER;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; FEMALE; HUMANS; MALE; MIDDLE AGED; OPTIC CHIASM; OPTIC NERVE DISEASES; PERIMETRY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOFTWARE; VISION DISORDERS; VISUAL FIELDS;

EID: 41949122858     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-0241     Document Type: Article

References (17)

1. Maddess T, Goldberg I, Dobinson J, et al. Testing for glaucoma with the spatial frequency doubling illusion. Vision Res. 1999; 39(25):4258-4273.
2. White AJ, Sun H, Swanson WH, Lee BB. An examination of physiological mechanisms underlying the frequency-doubling illusion. Invest Ophthalmol Vis Sci. 2002;43(11):3590-3599.
3. Johnson CA. Selective versus nonselective losses in glaucoma. J Glaucoma. 1994;3(suppl):S33-S44.
4. Cello KE, Nelson-Quigg JM, Johnson CA. Frequency doubling technology perimetry for detection of glaucomatous visual field loss. Am J Ophthalmol. 2000;129(3):314 -322.
5. Johnson CA, Samuels SJ. Screening for glaucomatous visual field loss with frequency-doubling perimetry. Invest Ophthalmol Vis Sci. 1997;38(2):413- 425.
6. Quigley HA. Identification of glaucoma-related visual field abnormality with the screening protocol of frequency doubling technology. Am J Ophthalmol. 1998;125(6):819-829.
7. Anderson AJ, Johnson CA. Frequency-doubling technology perimetry. Ophthalmol Clin North Am. 2003;16(2):213-225.
8. Girkin CA, McGwin G Jr, DeLeon-Ortega J. Frequency doubling technology perimetry in non-arteritic ischaemic optic neuropathy with altitudinal defects. Br J Ophthalmol. 2004;88(10):1274-1279.
9. Sakai T, Matsushima M, Shikishima K, Kitahara K. Comparison of standard automated perimetry with matrix frequency-doubling technology in patients with resolved optic neuritis. Ophthalmology. 2007;114(5):949 -956.
10. Wall M, Neahring RK, Woodward KR. Sensitivity and specificity of frequency doubling perimetry in neuro-ophthalmic disorders: a comparison with conventional automated perimetry. Invest Ophthalmol Vis Sci. 2002;43(4):1277-1283.
11. Anderson AJ, Johnson CA, Fingeret M, et al. Characteristics of the normative database for the Humphrey matrix perimeter. Invest Ophthalmol Vis Sci. 2005;46(4):1540-1548.
12. Keltner JL, Johnson CA, Beck RW, et al. Quality control functions of the Visual Field Reading Center (VFRC) for the Optic Neuritis Treatment Trial (ONTT). Control Clin Trials. 1993;14(2):143-159.
13. Keltner JL, Johnson CA, Cello KE, et al. Classification of visual field abnormalities in the ocular hypertension treatment study. Arch Ophthalmol. 2003;121(5):643- 650.
14. Keltner JL, Johnson CA, Levine RA, et al. Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study. Arch Ophthalmol. 2005; 123(9):1201-1206.
15. Keltner JL, Johnson CA, Spurr JO, Beck RW. Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group. Arch Ophthalmol. 1993;111(2):231-234.
16. Keltner JL, Johnson CA, Spurr JO, Beck RW. Visual field profile of optic neuritis: one-year follow-up in the Optic Neuritis Treatment Trial. Arch Ophthalmol. 1994;112(7):946 -953.
17. Anderson DR, Patella VM. Automated Static Perimetry. 2nd ed. St. Louis: Mosby; 1999:152-153.